BC 047 – Diagnostic de la thrombophlébite profonde par les D-Dimères ajustés à la probabilité clinique (étude 4D)

Dans cette 47e baladodiffusion, les Drs Luc Lanthier et Geneviève LeTemplier discutent de diagnostic de l’embolie pulmonaire avec l’étude 4D, en plus de réviser la littérature médicale de février 2022.

Quiz clinique (4 min 18), étude principale (4 min 40), critique (27 min 22), autres articles (31 min 46), réponse au quiz clinique (33 min 54) Référence principale Kearon C, de Wit K, Parpia S, Schulman S, Spencer FA, Sharma S, et al.

Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study.

BMJ. 2022;376:e067378.

Articles associés Linkins LA, Bates SM, Lang E, Kahn SR, Douketis JD, Julian J, et al.

Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial.

Ann Intern Med. 2013;158(2):93-100.

PubMed PMID: 23318311.

Lim W, Le Gal G, Bates SM, Righini M, Haramati LB, Lang E, et al.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism.

Blood Adv. 2018;2(22):3226-56.

PubMed PMID: 30482764.

Opstal TSJ, van Broekhoven A, Fiolet ATL, Mosterd A, Eikelboom JW, Nidorf SM, et al.

Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.

Circulation. 2022;145(8):626-8.

PubMed PMID: 35188792.

Pries-Heje MM, Wiingaard C, Ihlemann N, Gill SU, Bruun NE, Elming H, et al.

Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial.

N Engl J Med. 2022 Feb 10;386(6):601-602.

PubMed PMID: 35139280.

Therapeutics and COVID-19: living guideline (magicapp.org) Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, et al.

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Lancet. 2022;399(10325):665-76.

PubMed PMID: 35151397.

Perkins GD, Ji C, Connolly BA, Couper K, Lall R, Baillie JK, et al.

Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.

JAMA. 2022;327(6):559-65.

PubMed PMID: 35072713.

Heesakkers H, van der Hoeven JG, Corsten S, Janssen I, Ewalds E, Simons KS, et al.

Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19.

JAMA. 2022;327(6):546-58.

PubMed PMID: 35072716.

Kingery JR, Safford MM, Martin P, Lau JD, Rajan M, Wehmeyer GT, et al.

Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection.

J Gen Intern Med. 2022.

Epub 2022/01/26. doi: 10.1007/s11606-021-07379-z.

PubMed PMID: 35075531.

Xie Y, Xu E, Al-Aly Z.

Risks of mental health outcomes in people with covid-19: cohort study.

BMJ. 2022;376:e068993.

PubMed PMID: 35172971.

Ulloa AC, Buchan SA, Daneman N, Brown KA.

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.

JAMA. 2022.

Epub 2022/02/18. doi: 10.1001/jama.2022.2274.

PubMed PMID: 35175280.

Autres articles d’intérêt en févier MacIntyre IM, Turtle EJ, Farrah TE, Graham C, Dear JW, Webb DJ, et al.

Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.

Circulation. 2022;145(6):416-23.

PubMed PMID: 35130054.

Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al.

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.

Lancet. 2022;399(10325):629-55.

PubMed PMID: 35065702.

Neale RE, Baxter C, Romero BD, McLeod DSA, English DR, Armstrong BK, et al.

The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality.

Lancet Diabetes & Endocrinology. 2022;10(2):120-8.

PubMed PMID: 35026158.

Référence du quiz clinique Antoniou T, Bodkin J, Ho JM.

Drug interactions with cannabinoids.

CMAJ. 2020;192(9):E206.

PubMed PMID: 32122975.